Filing Details
- Accession Number:
- 0000899243-17-006986
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-03-09 16:06:25
- Reporting Period:
- 2017-03-09
- Filing Date:
- 2017-03-09
- Accepted Time:
- 2017-03-09 16:06:25
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1559053 | Prothena Corp Plc | PRTA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1457013 | Tran Nguyen | C/O Prothena Biosciences Inc 331 Oyster Point Boulevard South San Francisco CA 94080 | Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Ordinary Shares, Par Value $0.01 Per Share | Acquisiton | 2017-03-09 | 1,000 | $51.32 | 3,200 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The shares were purchased in multiple trades at prices ranging from $51.2492 to $51.46 inclusive. The price reported in Column 4 above reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.